英文摘要 |
Background: A long-acting analgesic may be particularly desirable in patients with long-lasting pain. In order to provide a long-acting analgesic effect, a novel buprenorphine ester, buprenorphine palmitate, was synthesized in our laboratory. The aim of the study was to evaluate whether the ester had a long-lasting effect. Methods: The antinociceptive effects (dose-range studies) of buprenorphine HC1 and buprenorphine palmitate were evaluated using the plantar test in Sprague-Dawley rats. Results: We found that intramuscular injection of buprenorphine HC10.05, 0.1 and 1 ^mol/kg in rats produced dose-related antinociceptive effects of 2, 3, and 4 h, respectively. Intramuscular injection of buprenorphine pal-mitate 1, 5, and 10 ^mol/kg also produced dose-related antinociceptive effects of 72, 76 and 78 h, respectively. On an equimolar basis of 1 ^mol/kg, the durations of action of intramuscular buprenorphine HC1 and buprenorphine palmitate were 4 and 72 h, respectively. Conclusions: Intramuscular injection of buprenorphine palmitate in rats produced a long-lasting antinocicep-tive effect which was much longer (18-fold) than did intramuscular buprenorphine HC1. |